Semaglutide found to reduce severity of common liver disease in people with HIV
A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the ...
Mar 5, 2024
0
0